Delivery Order SPE2DR25D1201-SPE2DR26FAKBB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 7, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine used for immunization against multiple meningococcal serogroups. This competitively awarded, non-set-aside contract has a ceiling value of $1,678.60 with a firm fixed price structure and an ultimate completion date of February 10, 2025. The work will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract is valued at $1,007.16 with a completion date of October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product, valued at $9,491.96. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by October 15, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,342.88 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract was awarded on July 28, 2025, with completion targeted for July 29, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,678.60 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract, executed on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for $5,035.80 to supply MENVEO A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of September 30, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded contract with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded procurement. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,193.10 delivery order on November 25, 2025, for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $47,123.20 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order is expected to be completed by December 9, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its distribution operations...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKBBDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,316.77 on December 9, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine used for immunization against multiple strains of meningococcal disease. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process typical of DLA medical supply acquisitions. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp provides comprehensive medical supplies and pharmaceuticals to support Defense Health Agency requirements and broader military healthcare operations worldwide. The company's role as a prime vendor under this global contract vehicle enables efficient fulfillment of ongoing vaccine and pharmaceutical needs across the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 12/8/25 |